InvestSMART

Wellnex Life Limited (ASX: WNX) - Announcements

- Current share price for WNX : $0.072

ASX company news and announcements for Wellnex Life Limited (WNX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Wellnex Life Limited (WNX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Wellnex Life Limited (WNX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Wellnex Life Limited (WNX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Notice of Extraordinary General Meeting/Proxy Form 9 Jun 2023 3:55PM $0.053 $0.072 risen by 35.85%
$5 Extension of Voluntary Suspension 31 May 2023 9:20AM $0.053 $0.072 risen by 35.85%
$5 Proposed issue of securities - WNX 26 May 2023 3:31PM $0.053 $0.072 risen by 35.85%
$5 Proposed issue of securities - WNX 26 May 2023 3:30PM $0.053 $0.072 risen by 35.85%
$5 Application for quotation of securities - WNX 26 May 2023 3:18PM $0.053 $0.072 risen by 35.85%
$5 Investor Presentation 25 May 2023 3:03PM $0.053 $0.072 risen by 35.85%
$5 Wellnex Entered into Binding Agreement to Acquire Pain Away 25 May 2023 3:03PM $0.053 $0.072 risen by 35.85%
$5 Suspension from Official Quotation 22 May 2023 10:28AM $0.053 $0.072 risen by 35.85%
$5 Trading Halt 18 May 2023 9:16AM $0.053 $0.072 risen by 35.85%
$5 Appendix 4C and Quarterly Report for March 2023 Quarter 28 Apr 2023 9:01AM $0.064 $0.072 risen by 12.50%
$5 Trading Update 12 Apr 2023 8:55AM $0.066 $0.072 risen by 9.09%
$5 Investor Briefing 15 Mar 2023 8:38AM $0.070 $0.072 risen by 2.86%
$5 Wellnex to Enter the SAS-B Medicinal Cannabis Market with CW 14 Mar 2023 8:49AM $0.065 $0.072 risen by 10.77%
$5 Wellnex Life Releases Half Year Report 28 Feb 2023 4:31PM $0.068 $0.072 risen by 5.88%
$5 Half Yearly Report and Accounts 28 Feb 2023 4:30PM $0.068 $0.072 risen by 5.88%
$5 Pharmacy Own Products Update 14 Feb 2023 8:08AM $0.068 $0.072 risen by 5.88%
$5 Appendix 3Y - KL 9 Feb 2023 3:02PM $0.067 $0.072 risen by 7.46%
$5 Appendix 3Y - EJ 9 Feb 2023 3:01PM $0.067 $0.072 risen by 7.46%
$5 Appendix 3Y - ZB 9 Feb 2023 3:01PM $0.067 $0.072 risen by 7.46%
$5 Appendix 3Y - GK 9 Feb 2023 3:00PM $0.067 $0.072 risen by 7.46%
$5 Notification regarding unquoted securities - WNX 9 Feb 2023 9:08AM $0.070 $0.072 risen by 2.86%
$5 Notification regarding unquoted securities - WNX 9 Feb 2023 9:06AM $0.070 $0.072 risen by 2.86%
$5 Notification regarding unquoted securities - WNX 9 Feb 2023 9:04AM $0.070 $0.072 risen by 2.86%
$5 Appendix 4C and Quarterly Report for December 2022 Quarter 24 Jan 2023 9:03AM $0.074 $0.072 fallen by 2.70%
$5 Trading Update - Half Year Ended 31 December 2022 9 Jan 2023 8:58AM $0.060 $0.072 risen by 20%

326 - 350 of 456 results

Page 14 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.